Skip to Main Content

Paper Details

PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS.
Acta Oncol
9
2021
EBER, Epstein-Barr virus encoding RNA, IDO1, Indoleamine, Indoleamine 2,3-deoxygenase, PAX-5, PCNSL, PD, PD-, PD-1, PD-L1, PD-L1 positive leukocytes, PD-L2, Programmed cell death 1, RNA, TMAs, diffuse large B-cell lymphoma, leukocytes, paired box protein 5, patients, positive leukocytes, primary diffuse large B-cell lymphoma of the CNS, tumor, tumor and microenvironmental cells
Author NameAffiliation
Claes LadenvallClinical Genomics Uppsala, Uppsala University
Cecilia LindskogUppsala University
Cecilia LindskogUppsala University
  • 1 - 3

Datasets

Release 1.2